<SEC-DOCUMENT>0001193125-14-112835.txt : 20140325
<SEC-HEADER>0001193125-14-112835.hdr.sgml : 20140325
<ACCEPTANCE-DATETIME>20140324213329
ACCESSION NUMBER:		0001193125-14-112835
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140324
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140325
DATE AS OF CHANGE:		20140324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOFIX INTERNATIONAL N V
		CENTRAL INDEX KEY:			0000884624
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19961
		FILM NUMBER:		14714408

	BUSINESS ADDRESS:	
		STREET 1:		7 ABRAHAM DE VEERSTRAAT
		STREET 2:		CURACAO
		CITY:			NETHERLANDS ANTILLES
		STATE:			P8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d698968d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): March&nbsp;24, 2014 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix International N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Cura&ccedil;ao</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-19961</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7 Abraham de Veerstraat</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cura&ccedil;ao</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip&nbsp;Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: 011-59-99-465-8525 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see</I> General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;7.01. <U>Regulation FD Disclosure</U>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;24, 2014, Orthofix International N.V. (the &#147;Company&#148;) issued a press release that is furnished herewith as Exhibit
99.1. The information included in this Current Report on Form 8-K under this Item&nbsp;7.01 (including Exhibit&nbsp;99.1) shall not be deemed &#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended
(the &#147;<U>Exchange Act</U>&#148;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended,
except as shall be expressly set forth by specific reference in such a filing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. <U>Financial Statements and Exhibits</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top">Press Release, dated March&nbsp;24, 2014.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Orthofix International N.V.</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeffrey M. Schumm</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey M. Schumm</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Administrative Officer,
General Counsel and Corporate Secretary</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;24, 2014 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated March 24, 2014.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d698968dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g698968g54e97.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix, International N.V.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">3451 Plano Parkway</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Lewisville, TX 75056 USA</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Tel 214 937 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>News Release </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONTACT:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Mark Quick </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Tel 214 937 2924 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">markquick@orthofix.com
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix Announces Filing of Restated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Restatement Set Forth in Amended Annual and Quarterly Reports Filed with SEC </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Company to Host Conference Call on Thursday, March&nbsp;27 in Connection With Full-Year 2013 Results </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LEWISVILLE, Texas &#151; March&nbsp;24, 2014 &#151; Orthofix International N.V. (NASDAQ:OFIX) (&#147;Orthofix&#148; or the &#147;Company&#148;) today
announced that it has completed the filing of its previously announced financial statement restatement. The restatement is described in an amendment to the Company&#146;s annual report on Form 10-K/A for the fiscal year ended December&nbsp;31, 2012
(the &#147;Form 10-K/A&#148;) and an amendment to the Company&#146;s quarterly report on Form 10-Q for the fiscal quarter ended March&nbsp;31, 2013 (the &#147;Form 10-Q/A,&#148; and collectively with the Form 10-K/A, the &#147;Amendments&#148;),
each of which have been filed today with the Securities and Exchange Commission (the &#147;SEC&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contemporaneously with the filing of the
Amendments, the Company has today filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June&nbsp;30, 2013. The Company expects to file with the SEC its Quarterly Report on Form 10-Q for the fiscal quarter ended September&nbsp;30,
2013 on March&nbsp;25, 2014. Additionally, the Company plans to release earnings results for the year ended December&nbsp;31, 2013 on the morning of March&nbsp;27, 2014. The Company currently expects to file its Annual Report on Form 10-K for the
year ended December&nbsp;31, 2013 by March&nbsp;31, 2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The Audit Committee, with the assistance of independent outside professionals, has
conducted a thorough review of these matters,&#148; said Davey S. Scoon, Chairman of the Audit Committee of the Company&#146;s Board of Directors. &#147;The Audit Committee has concluded its review and is confident that the Company is appropriately
addressing the matters, including the internal control over financial reporting weaknesses that led to the restatement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The restated financial
statements were prepared by the Company&#146;s management in conjunction with the previously announced independent review (the &#147;Independent Review&#148;) into these matters conducted by the Audit Committee. The scope of the Independent Review,
which was determined by the Audit Committee in consultation with outside professionals engaged by the Audit Committee, focused primarily on revenue recognition related to distributor arrangements and inventory reserve adjustments. In conjunction
with the Independent Review, management concluded that errors existed in the Company&#146;s previously issued consolidated financial statements with respect to fiscal years 2012, 2011 and 2010, and the first quarter of 2013. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, similar types of errors were identified in the Company&#146;s previously issued consolidated financial statements of 2009, 2008 and 2007, for
which the Company has included restated financial information for 2009 and 2008 in the &#147;Selected Financial Data&#148; table of the Form 10-K/A. Adjustments prior to 2010 are recognized as a cumulative adjustment to beginning retained earnings
as of January&nbsp;1, 2010 in the consolidated statements of changes in shareholders&#146; equity included in the audited </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g698968g54e97.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">3451 Plano Parkway</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Lewisville, TX 75056 USA</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Tel 214 937 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix.com</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consolidated financial statements contained in the Form 10-K/A. In addition to the matters that were the subject of the Independent Review, certain other adjustments identified by the
Company&#146;s management, including revisions to inventory reserves and royalties, were made to the consolidated financial statements in connection with the restatement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effects of the Restatement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The restatement of the
Company&#146;s previously issued consolidated financial statements resulted in, among others, the following changes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a reduction in net sales for the years ended December&nbsp;31, 2012 and 2011 of $14.7 million and $28.2 million, respectively, and an increase in net sales for the year ended December&nbsp;31, 2010 of $1.9 million;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a decrease in net income from continuing operations for the years ended December&nbsp;31, 2012 and 2011 of $8.9 million and $14.5 million, and an increase in net income from continuing operations for the year ended
December&nbsp;31, 2010 of $3.2 million; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a decrease in opening retained earnings and total stockholders&#146; equity at January&nbsp;1, 2010 of $8.3 million and $7.6 million, respectively. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Remedial Action </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is committed to maintaining
an effective control environment and making changes necessary to enhance effectiveness. This commitment has been, and will continue to be, communicated to and reinforced throughout the Company. As part of this commitment, the Company is implementing
an internal audit program that will take into account the nature of the Company&#146;s business and the geographies in which the Company conducts it. The Company is also updating its code of conduct, and all its employees will be required to
annually acknowledge their commitment to adhering to its provisions. The Company also will inform all new employees and regularly remind all existing employees of the availability of its compliance hotline, through which employees at all levels can
anonymously submit information or express concerns regarding accounting, financial reporting and other irregularities they may have become aware of or observed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is in the process of developing a plan for remediation of its internal control over financial reporting. In addition, it has designed and plans to
implement, and in some cases has already implemented, the specific remediation initiatives described below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Remediation plan with
respect to controls over revenue recognition practices relating to the Company&#146;s distributors: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Enhanced revenue recognition training materials for all sales personnel. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In the process of training sales management personnel (including senior-level management) pursuant to our updated revenue recognition training materials. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Created and implemented an improved sales certification process to identify any sales with deviations from written sales contracts. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Established and hired a new Senior Manager of Revenue position in the finance department, which the Company believes will bring additional revenue recognition expertise to address our more complex revenue transactions
to help ensure that our revenue recognition policies are correctly applied. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g698968g54e97.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">3451 Plano Parkway</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Lewisville, TX 75056 USA</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Tel 214 937 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix.com</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Working to improve procedures with respect to the proper communication, approval, documentation and accounting review of deviations from written sales contracts. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Remediation plan with respect to controls over the computation and recording of the Company&#146;s inventory reserves: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Enhanced controls over the model for determining inventory reserves to ensure that, once reserves are established in a fiscal year, subsequent write-ups based on demand are not recognized. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Implementing additional review of inventory reserve analysis, including the involvement of both finance and operational executives, and more analysis of days inventory on hand at the product line level, which we expect
to provide better controls to assess excess and obsolete inventory based on the current inventory on hand in relation to the demand forecast and related reserve. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Remediation plan with respect to controls over foreign subsidiary oversight: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changed structure so that all subsidiaries&#146; accounting functions now report to the VP, Controller within the corporate accounting function, which we believe will provide additional corporate-level oversight of
their activities. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Established and hired a Director of Controls and Process Improvement, whose primary duties are the design and implementation of internal control over financial reporting. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Engaged a professional firm to perform testing and evaluation of the Company&#146;s internal controls, and to assist the Company in designing and implementing additional financial reporting controls and financial
reporting control enhancements. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Evaluating accounting systems to determine appropriate enhancements. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brad Mason, President and Chief
Executive Officer, said, &#147;The past year has presented us with a unique set of challenges, but we are confident Orthofix is emerging stronger and with a renewed energy to drive our business forward. We are committed to achieving and maintaining
a strong control environment, high ethical standards and financial reporting integrity. This commitment has been and will continue to be communicated to every Orthofix employee. It is accompanied by renewed management focus on strategies and
processes intended to drive long-term shareholder value.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Orthofix </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. is a diversified, global medical device company focused on improving patients&#146; lives by providing superior reconstructive and
regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely
distributed via the company&#146;s sales representatives, stocking distributors and its subsidiaries. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as the Musculoskeletal
Transplant Foundation, the Orthopedic Research and Education Foundation and the Texas Scottish Rite Hospital for Children. For more information, please visit <U>www.orthofix.com</U>. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g698968g54e97.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">3451 Plano Parkway</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Lewisville, TX 75056 USA</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Tel 214 937 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:10.00em; font-size:10pt; font-family:Times New Roman">Orthofix.com</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains certain forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements,
which may include, but are not limited to, statements concerning the projections, financial condition, results of operations and businesses of Orthofix and its subsidiaries and are based on management&#146;s current expectations and estimates and
involve risks and uncertainties that could cause actual results or outcomes to differ materially from those contemplated by the forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this release do not constitute guarantees or promises of future performance. Factors that could cause or contribute to such
differences may include, but are not limited to: risks relating to the Audit Committee review and financial restatement described herein and related legal proceedings (including potential action by the Division of Enforcement of the SEC and pending
securities class action litigation); the Company&#146;s review of allegations of improper payments involving the Company&#146;s Brazil-based subsidiary; the Company&#146;s non-compliance with certain NASDAQ Stock Market listing rules, and related
pending hearings proceedings in connection therewith; the expected sales of the Company&#146;s products, including recently launched products; unanticipated expenditures; changing relationships with customers, suppliers, strategic partners and
lenders; changes to and the interpretation of governmental regulations; the resolution of pending litigation matters (including the Company&#146;s indemnification obligations with respect to certain product liability claims against, and the
government investigation of, the Company&#146;s former sports medicine global business unit, as further described in the &#147;Legal Proceedings&#148; section of the Form 10-K/A, and other subsequent periodic reports filed by the Company with the
SEC); the Company&#146;s ongoing compliance obligations under a corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services (and related terms of probation) and a deferred prosecution agreement
with the U.S. Department of Justice; risks relating to the protection of intellectual property; changes to the reimbursement policies of third parties; the impact of competitive products; changes to the competitive environment, the acceptance of new
products in the market, conditions of the orthopedic industry, credit markets and the economy; corporate development and market development activities, including acquisitions or divestitures, unexpected costs or operating unit performance related to
recent acquisitions; and other risks described in Item&nbsp;1A under the heading &#147;Risk Factors&#148; in the Form 10-K/A, as well as in other subsequent periodic reports filed by the Company with the SEC. Existing and prospective investors are
cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information contained in this press release. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g698968g54e97.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g698968g54e97.jpg
M_]C_X0NB17AI9@``34T`*@````@`"`$2``,````!``$```$:``4````!````
M;@$;``4````!````=@$H``,````!``(```$Q``(````>````?@$R``(````4
M````G`$[``(````-````L(=I``0````!````P````.P`+<;````G$``MQL``
M`"<0061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-#HP,SHR-2`P
M-3HP,CHT-`!3:&%W;B!(96QL97(```````.@`0`#`````0`!``"@`@`$````
M`0```02@`P`$`````0```"D`````````!@$#``,````!``8```$:``4````!
M```!.@$;``4````!```!0@$H``,````!``(```(!``0````!```!2@("``0`
M```!```*4`````````!(`````0```$@````!_]C_[0`,061O8F5?0TT``?_N
M``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43
M$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-
M$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#/_``!$(`!D`H`,!(@`"$0$#$0'_W0`$``K_Q`$_```!
M!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$`
M`@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@`,`P$``A$#$0`_`.]^L.;;CU555=2IZ79DO%55CZOM%KWN<VMK,;&WU_G/
M;O?LR/['\XO-?K%TGK/2\_\`RK8[(LNDU9A>YXL#?![_`'U65M_P'YG^!_1J
MEE9&<.HV95[W69]5Q+K+"2[?2_VL)=]%K'U[?3^@Q>H=9JQ/K+]5++L>'BRG
M[3B.T);:P%[&_P`A^\/Q[_\`KM2OQ!Y8PNI1GI,UM_A-"4AS(F-8RQZQ%_G%
MYOZD?6W+;F5](ZE:Z^G(.W%OL.Y[+/I"BRU_OLJN_P`%N_25V_HOYNS]#W'4
M^J].Z3AOS>I7LQL9G+W]SSL8ULOLL_X.OWKQ?$LL&3C6T3ZHMJ?5'.[>QU?_
M`$EO?X\G9$=';)^SGUR0)@O'H?3_`#?H._1_]<4?.XXPF#$5Q#4>(9.2RRG`
MB6O`:MWW?XV_JO-AIJS<BJKZ5]='LC][])96]O\`;8MWH'UO^K_UB#F]+RA9
M=6W=9CO!9:T:#=Z=D;V-<YOZ2K?6KO1Z>FT=+Q:^E!@Z>*FG&]/Z)81N:_\`
ME>INWN?^>O*/U;&_QR._9&QE;+'>H*XV!PQG.SQI[?:_U_4_X=5&V][U?_&-
M]4ND95F'DYALR:7;;:Z&.LVN'TF/L:/2WL_/9ZF^M"Z9_C-^J'4LNO#JRG57
M7.#*A=6Y@<YVC6^I#JV_]<7G7^+0?65AS<SH/3L3.O:YC+,C*=#ZPX/.VG])
M6[;;_A58S/VU]??K73T/KHQ>CY/3M[7U-:X6O;[7W,I<YUS,BS8SU:?TC*?1
M_3U^JDI[6S_&U]4*K'U6/R&OK<6O::7`@M.TR%`_XWOJ;$^ID'_K)_O6I_C#
M)_YE]5_XD?\`5L65_B?)_P"9S?+)MC_H)*=G%^NG1,KKK>@U&W[<]C;6@L(9
MM=4S-;[_`,W]#9_GJS]8OK+TSZMX=>;U(O%-M@I::V[SO+7V#3^K4Y>97_M@
M?XWLW]BC'.?[O3&7O]*/L[?4W>A^DW;/H(G^,UWUV/0<?_G`WIS<3[6WT_L7
MJ^IZGIW;=WKDL]+T_5_MI*?0NH_77ZN=+Z=B]0SLKT:\ZMMV-5M<ZU[7M]5O
MZ"L.>WV_GO\`T>]8@_QN_5>&/LIS:J;##;WTC9_G-L<YW]EJX2IF%D?7_HM/
M6/?TW[+@-I9;K66_8Z78]<.]KJ'YY_2-_F_YWU%[7FMPWX=S<X5G#+'?:/6C
MT_3C])ZN_P!GI[/I[TE-;IW7NC]3Z<[JF%EUVX+-QLOG:UFP;[/7]78ZC8S]
M([UMGZ/WKG\C_&O]2Z;#6S*LO(,%U5+R-/-[:]W]E>5=$LNK^K7UJ^S.<,0U
MXK2>"2<IC:0[^M1]H79_4-GU[Q_JUBOZ#B=).'>;'^K?ZHO>X665N=D&JQC7
M.;LV5_\``^FDIZ2C_&C]5;ZLFVM]^W#J%]TU$'8;*L4;=?=^ER:D7(_QC?5_
M'Z7B]7>W).!FNL95>VHEH?6[8:;/=^CLLVNLI_TE;+/]&LKZY/\`K$__`!<=
M6/UAKQJLSU*16W#W&OTO6Q-I=ZSK'>IZGJI?41G2'_XL6MZV*STPB_[3ZNC=
MOJOUT]_J;]OH^G^E]79Z/Z5)3UC_`*P]&;T7]O?:F'IGI^J,@3!:3MV[?I^M
MZGZ+T-OJ^M^A_G%GX'UZZ)G8C,VIF0S&MM;15:^D@/>[=N%6W<Y_H[?TJ\59
MZ4M;:[.=]3&]0<`8`=O+?SH_5_MGV7_P/U/37O6#A]"R^F8?V*JF[I[&`X>T
M`L#(_,G_`,$W?]=24__0M_7CZL96-U"SJF%2Z[$S';KFUM+W57'Z;G5LW/\`
M2R7>_?\`Z?U/])6C]!QNO_5WI>7G9SAC8%K'>GT^P%]]N18W9C>A76?U6V^U
MU;/3_366?X3&J_GEZ$J6;_3NG_\`'/\`_/-ROGWO8CQ\'#IO\_#^BT8^S[\N
M#BX]=OD_K/$_4[ZD9[<O&ZEU6OT*<:+*<9W\ZZQH'HV6M;_,UUN_2>GN];U?
MYVNO_"=MUCHO3.MX+L#JE#<C'<0X-,@M<WZ-E=C-ME;_`.4QWT/T?T%=3J#F
MO=]S]96WIX?EX?ZK/RWM\'ZO:];^;B_K/%4_XK.F8U3L?$ZOU;&QGDEV/5DM
M:S7GV-I_ZI:?0/J)]7_J_3<S`K?Z^16:;<NQVZXL/YK';6U5?]:J]_\`A/H+
MHDE79W!^JOU-Z9]5:\FOIUM]HRBQUGVAS706!P;L]*NG]]"^L7U$Z-]8,_'Z
ME?9D8>=C0&9&(]M;SM.^ISG/KM]]#_YJQFQ__071I)*<_JO1Z>K='MZ1F6VF
MJ]@KMN;M;:8+7;_YOT6O?M]WZ'T_Y"%]6_JY@_5OIO[-P7VV4A[K-UQ:YTNB
M=:V5-V^W]Q:J22GGZ?J3TJGZTO\`K0VW(.=9,UES/1]S/L_T/2]7Z'_#(_UH
M^JW3_K1@5X'4++JJJK1>TT.:UVX-?5[O5KN;MVVN_-6RDDIYSJOU`^KG5NG8
MF#F5/<[`H9C8^6UVV\5L`8W=8UOIV_1_PM7I_P`YZ;%FV?XK.FW8[<3(ZOU:
M[$;&W&?D-=6`WZ(],T;/:NU224\[=]0OJ\[ZO6?5['K?B8=SFV6OI</5<YCA
M9O?=>V[?]'\[_K:TN@]%Q>@])HZ3AOLLQ\;=L=:0YYWO?<[<YC:V?3L_<6@D
MDIS^O]$Q>O=)OZ3F/LKQ\G9O=40'C8]E[=KK&VL^G5^XL#(_Q9]'R.C8O1'9
MN<S`PW/>RMEE0WO>YUGJ7_JY:]S-^RK]Q=>DDIS7_5WH[NAGH'V9C>F&OTA0
MW@"=^\.^EZWJ?IO6_G?7_3?SBJ_5CZIXGU8HLQL'+RK\:P[A3DN8]K'?G/I]
M.FES-_YZW$DE/__9_^T40E!H;W1O<VAO<"`S+C``.$))300$``````!E'`%:
M``,;)4<<`@```I*@'`)0``Q3:&%W;B!(96QL97(<`@4`0$I&($5$2513("T@
M3T9)6"!$4D%&5"!0<F5S<R!296QE87-E(')E($9I;&EN9R!O9B!297-T871E
M9"!&:6YA;F,`.$))300E```````0"R?=MGH;A@VQ$;%A,KB/*CA"24T$.@``
M````_0```!`````!```````+<')I;G1/=71P=70````%`````%!S=%-B;V]L
M`0````!);G1E96YU;0````!);G1E`````$-L<FT````/<')I;G13:7AT965N
M0FET8F]O;``````+<')I;G1E<DYA;65415A4````#0!(`%``(``H`$$`4`!.
M`"``-``U`#,`*0``````#W!R:6YT4')O;V93971U<$]B:F,````,`%``<@!O
M`&\`9@`@`%,`90!T`'4`<```````"G!R;V]F4V5T=7`````!`````$)L=&YE
M;G5M````#&)U:6QT:6Y0<F]O9@````EP<F]O9D--64L`.$))300[``````(M
M````$`````$``````!)P<FEN=$]U='!U=$]P=&EO;G,````7`````$-P=&YB
M;V]L``````!#;&)R8F]O;```````4F=S36)O;VP``````$-R;D-B;V]L````
M``!#;G1#8F]O;```````3&)L<V)O;VP``````$YG='9B;V]L``````!%;6Q$
M8F]O;```````26YT<F)O;VP``````$)C:V=/8FIC`````0```````%)'0D,`
M```#`````%)D("!D;W5B0&_@````````````1W)N(&1O=6)`;^``````````
M``!";"`@9&]U8D!OX````````````$)R9%15;G1&(U)L=```````````````
M`$)L9"!5;G1&(U)L=````````````````%)S;'15;G1&(U!X;$!RP```````
M````"G9E8W1O<D1A=&%B;V]L`0````!09U!S96YU;0````!09U!S`````%!G
M4$,`````3&5F=%5N=$8C4FQT````````````````5&]P(%5N=$8C4FQT````
M````````````4V-L(%5N=$8C4')C0%D````````````08W)O<%=H96Y0<FEN
M=&EN9V)O;VP`````#F-R;W!296-T0F]T=&]M;&]N9P`````````,8W)O<%)E
M8W1,969T;&]N9P`````````-8W)O<%)E8W12:6=H=&QO;F<`````````"V-R
M;W!296-T5&]P;&]N9P``````.$))30/M```````0`2P````!``(!+`````$`
M`CA"24T$)@``````#@`````````````_@```.$))300-```````$````>#A"
M24T$&0``````!````!XX0DE-`_,```````D```````````$`.$))32<0````
M```*``$``````````CA"24T#]0``````2``O9F8``0!L9F8`!@```````0`O
M9F8``0"AF9H`!@```````0`R`````0!:````!@```````0`U`````0`M````
M!@```````3A"24T#^```````<```_____________________________P/H
M`````/____________________________\#Z`````#_________________
M____________`^@`````_____________________________P/H```X0DE-
M!`@``````!`````!```"0````D``````.$))300>```````$`````#A"24T$
M&@`````#OP````8``````````````"D```$$````10!/`$8`20!8`"``4`!R
M`&4`<P!S`"``4@!E`&P`90!A`',`90`@`'(`90`@`$8`:0!L`&D`;@!G`"``
M;P!F`"``4@!E`',`=`!A`'0`90!D`"``1@!I`&X`80!N`&,`:0!A`&P`(`!3
M`'0`80!T`&4`;0!E`&X`=`!S`"``1@!)`$X`00!,`"T`,0````$`````````
M`````````````````0`````````````!!````"D`````````````````````
M`0`````````````````````````0`````0```````&YU;&P````"````!F)O
M=6YD<T]B:F,````!````````4F-T,0````0`````5&]P(&QO;F<`````````
M`$QE9G1L;VYG``````````!"=&]M;&]N9P```"D`````4F=H=&QO;F<```$$
M````!G-L:6-E<U9L3',````!3V)J8P````$```````5S;&EC90```!(````'
M<VQI8V5)1&QO;F<`````````!V=R;W5P241L;VYG``````````9O<FEG:6YE
M;G5M````#$53;&EC94]R:6=I;@````UA=71O1V5N97)A=&5D`````%1Y<&5E
M;G5M````"D53;&EC951Y<&4`````26UG(`````9B;W5N9'-/8FIC`````0``
M`````%)C=#$````$`````%1O<"!L;VYG``````````!,969T;&]N9P``````
M````0G1O;6QO;F<````I`````%)G:'1L;VYG```!!`````-U<FQ415A4````
M`0```````&YU;&Q415A4`````0```````$US9V5415A4`````0``````!F%L
M=%1A9U1%6%0````!```````.8V5L;%1E>'1)<TA434QB;V]L`0````AC96QL
M5&5X=%1%6%0````!```````):&]R>D%L:6=N96YU;0````]%4VQI8V5(;W)Z
M06QI9VX````'9&5F875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E
M<G1!;&EG;@````=D969A=6QT````"V)G0V]L;W)4>7!E96YU;0```!%%4VQI
M8V5"1T-O;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO;F<`````````
M"FQE9G1/=71S971L;VYG``````````QB;W1T;VU/=71S971L;VYG````````
M``MR:6=H=$]U='-E=&QO;F<``````#A"24T$*```````#`````(_\```````
M`#A"24T$%```````!`````(X0DE-!`P`````"FP````!````H````!D```'@
M```NX```"E``&``!_]C_[0`,061O8F5?0TT``?_N``Y!9&]B90!D@`````'_
MVP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4
M$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_`
M`!$(`!D`H`,!(@`"$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#
M``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!
M`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R
M@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%
MM)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#
M!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3
M%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D
M]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`.]^
ML.;;CU555=2IZ79DO%55CZOM%KWN<VMK,;&WU_G/;O?LR/['\XO-?K%TGK/2
M\_\`RK8[(LNDU9A>YXL#?![_`'U65M_P'YG^!_1JEE9&<.HV95[W69]5Q+K+
M"2[?2_VL)=]%K'U[?3^@Q>H=9JQ/K+]5++L>'BRG[3B.T);:P%[&_P`A^\/Q
M[_\`KM2OQ!Y8PNI1GI,UM_A-"4AS(F-8RQZQ%_G%YOZD?6W+;F5](ZE:Z^G(
M.W%OL.Y[+/I"BRU_OLJN_P`%N_25V_HOYNS]#W'4^J].Z3AOS>I7LQL9G+W]
MSSL8ULOLL_X.OWKQ?$LL&3C6T3ZHMJ?5'.[>QU?_`$EO?X\G9$=';)^SGUR0
M)@O'H?3_`#?H._1_]<4?.XXPF#$5Q#4>(9.2RRG`B6O`:MWW?XV_JO-AIJS<
MBJKZ5]='LC][])96]O\`;8MWH'UO^K_UB#F]+RA9=6W=9CO!9:T:#=Z=D;V-
M<YOZ2K?6KO1Z>FT=+Q:^E!@Z>*FG&]/Z)81N:_\`E>INWN?^>O*/U;&_QR._
M9&QE;+'>H*XV!PQG.SQI[?:_U_4_X=5&V][U?_&-]4ND95F'DYALR:7;;:Z&
M.LVN'TF/L:/2WL_/9ZF^M"Z9_C-^J'4LNO#JRG577.#*A=6Y@<YVC6^I#JV_
M]<7G7^+0?65AS<SH/3L3.O:YC+,C*=#ZPX/.VG])6[;;_A58S/VU]??K73T/
MKHQ>CY/3M[7U-:X6O;[7W,I<YUS,BS8SU:?TC*?1_3U^JDI[6S_&U]4*K'U6
M/R&OK<6O::7`@M.TR%`_XWOJ;$^ID'_K)_O6I_C#)_YE]5_XD?\`5L65_B?)
M_P"9S?+)MC_H)*=G%^NG1,KKK>@U&W[<]C;6@L(9M=4S-;[_`,W]#9_GJS]8
MOK+TSZMX=>;U(O%-M@I::V[SO+7V#3^K4Y>97_M@?XWLW]BC'.?[O3&7O]*/
ML[?4W>A^DW;/H(G^,UWUV/0<?_G`WIS<3[6WT_L7J^IZGIW;=WKDL]+T_5_M
MI*?0NH_77ZN=+Z=B]0SLKT:\ZMMV-5M<ZU[7M]5OZ"L.>WV_GO\`T>]8@_QN
M_5>&/LIS:J;##;WTC9_G-L<YW]EJX2IF%D?7_HM/6/?TW[+@-I9;K66_8Z78
M]<.]KJ'YY_2-_F_YWU%[7FMPWX=S<X5G#+'?:/6CT_3C])ZN_P!GI[/I[TE-
M;IW7NC]3Z<[JF%EUVX+-QLOG:UFP;[/7]78ZC8S]([UMGZ/WKG\C_&O]2Z;#
M6S*LO(,%U5+R-/-[:]W]E>5=$LNK^K7UJ^S.<,0UXK2>"2<IC:0[^M1]H79_
M4-GU[Q_JUBOZ#B=).'>;'^K?ZHO>X665N=D&JQC7.;LV5_\``^FDIZ2C_&C]
M5;ZLFVM]^W#J%]TU$'8;*L4;=?=^ER:D7(_QC?5_'Z7B]7>W).!FNL95>VHE
MH?6[8:;/=^CLLVNLI_TE;+/]&LKZY/\`K$__`!<=6/UAKQJLSU*16W#W&OTO
M6Q-I=ZSK'>IZGJI?41G2'_XL6MZV*STPB_[3ZNC=OJOUT]_J;]OH^G^E]79Z
M/Z5)3UC_`*P]&;T7]O?:F'IGI^J,@3!:3MV[?I^MZGZ+T-OJ^M^A_G%GX'UZ
MZ)G8C,VIF0S&MM;15:^D@/>[=N%6W<Y_H[?TJ\59Z4M;:[.=]3&]0<`8`=O+
M?SH_5_MGV7_P/U/37O6#A]"R^F8?V*JF[I[&`X>T`L#(_,G_`,$W?]=24__0
MM_7CZL96-U"SJF%2Z[$S';KFUM+W57'Z;G5LW/\`2R7>_?\`Z?U/])6C]!QN
MO_5WI>7G9SAC8%K'>GT^P%]]N18W9C>A76?U6V^UU;/3_366?X3&J_GEZ$J6
M;_3NG_\`'/\`_/-ROGWO8CQ\'#IO\_#^BT8^S[\N#BX]=OD_K/$_4[ZD9[<O
M&ZEU6OT*<:+*<9W\ZZQH'HV6M;_,UUN_2>GN];U?YVNO_"=MUCHO3.MX+L#J
ME#<C'<0X-,@M<WZ-E=C-ME;_`.4QWT/T?T%=3J#FO=]S]96WIX?EX?ZK/RWM
M\'ZO:];^;B_K/%4_XK.F8U3L?$ZOU;&QGDEV/5DM:S7GV-I_ZI:?0/J)]7_J
M_3<S`K?Z^16:;<NQVZXL/YK';6U5?]:J]_\`A/H+HDE79W!^JOU-Z9]5:\FO
MIUM]HRBQUGVAS706!P;L]*NG]]"^L7U$Z-]8,_'ZE?9D8>=C0&9&(]M;SM.^
MISG/KM]]#_YJQFQ__071I)*<_JO1Z>K='MZ1F6VFJ]@KMN;M;:8+7;_YOT6O
M?M]WZ'T_Y"%]6_JY@_5OIO[-P7VV4A[K-UQ:YTNB=:V5-V^W]Q:J22GGZ?J3
MTJGZTO\`K0VW(.=9,UES/1]S/L_T/2]7Z'_#(_UH^JW3_K1@5X'4++JJJK1>
MTT.:UVX-?5[O5KN;MVVN_-6RDDIYSJOU`^KG5NG8F#F5/<[`H9C8^6UVV\5L
M`8W=8UOIV_1_PM7I_P`YZ;%FV?XK.FW8[<3(ZOU:[$;&W&?D-=6`WZ(],T;/
M:NU224\[=]0OJ\[ZO6?5['K?B8=SFV6OI</5<YCA9O?=>V[?]'\[_K:TN@]%
MQ>@])HZ3AOLLQ\;=L=:0YYWO?<[<YC:V?3L_<6@DDIS^O]$Q>O=)OZ3F/LKQ
M\G9O=40'C8]E[=KK&VL^G5^XL#(_Q9]'R.C8O1'9N<S`PW/>RMEE0WO>YUGJ
M7_JY:]S-^RK]Q=>DDIS7_5WH[NAGH'V9C>F&OTA0W@"=^\.^EZWJ?IO6_G?7
M_3?SBJ_5CZIXGU8HLQL'+RK\:P[A3DN8]K'?G/I].FES-_YZW$DE/__9.$))
M300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`
M;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`$,`4P`V
M`````0`X0DE-!`8```````<`"`````$!`/_A#QMH='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP
M0V5H:4AZ<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O
M8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q
M(#8V+C$T-38V,2P@,C`Q,B\P,B\P-BTQ-#HU-CHR-R`@("`@("`@(CX@/')D
M9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R
M+7)D9BUS>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(@>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X
M;6QN<SIP9&8](FAT='`Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B('AM;&YS
M.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(@>&UL;G,Z
M>&UP34T](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS
M.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O4F5S
M;W5R8V5%=F5N=",B('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]P:&]T;W-H;W`O,2XP+R(@>&UP.D-R96%T941A=&4](C(P,30M,#,M
M,C54,#4Z,#$Z-3`K,#4Z,S`B('AM<#I#<F5A=&]R5&]O;#TB36EC<F]S;V9T
MPJX@3V9F:6-E(%=O<F0@,C`P-R(@>&UP.DUO9&EF>41A=&4](C(P,30M,#,M
M,C54,#4Z,#(Z-#0K,#4Z,S`B('AM<#I-971A9&%T841A=&4](C(P,30M,#,M
M,C54,#4Z,#(Z-#0K,#4Z,S`B('!D9CI0<F]D=6-E<CTB36EC<F]S;V9TPJX@
M3V9F:6-E(%=O<F0@,C`P-R(@9&,Z9F]R;6%T/2)I;6%G92]J<&5G(B!X;7!-
M33I$;V-U;65N=$E$/2)X;7`N9&ED.C8Y1D%#-#,S039",T4S,3%",30V13DT
M.44U,SDP,S8S(B!X;7!-33I);G-T86YC94E$/2)X;7`N:6ED.C8Y1D%#-#,S
M039",T4S,3%",30V13DT.44U,SDP,S8S(B!X;7!-33I/<FEG:6YA;$1O8W5M
M96YT240](GAM<"YD:60Z-CE&04,T,S-!-D(S13,Q,4(Q-#9%.30Y134S.3`S
M-C,B('!H;W1O<VAO<#I#;VQO<DUO9&4](C,B('!H;W1O<VAO<#I)0T-0<F]F
M:6QE/2)S4D="($E%0S8Q.38V+3(N,2(^(#QD8SIC<F5A=&]R/B`\<F1F.E-E
M<3X@/')D9CIL:3Y3:&%W;B!(96QL97(\+W)D9CIL:3X@/"]R9&8Z4V5Q/B`\
M+V1C.F-R96%T;W(^(#QD8SIT:71L93X@/')D9CI!;'0^(#QR9&8Z;&D@>&UL
M.FQA;F<](G@M9&5F875L="(^2D8@141)5%,@+2!/1DE8($120494(%!R97-S
M(%)E;&5A<V4@<F4@1FEL:6YG(&]F(%)E<W1A=&5D($9I;F%N8VEA;"!3=&%T
M96UE;G1S(&)R860N+BX@*#`P-3@W,34W+3$S*2Y$3T-8/"]R9&8Z;&D^(#PO
M<F1F.D%L=#X@/"]D8SIT:71L93X@/'AM<$U-.DAI<W1O<GD^(#QR9&8Z4V5Q
M/B`\<F1F.FQI('-T179T.F%C=&EO;CTB9&5R:79E9"(@<W1%=G0Z<&%R86UE
M=&5R<STB8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H
M;W1O<VAO<"!T;R!I;6%G92]J<&5G(B\^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N
M/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HV.49!0S0S,T$V
M0C-%,S$Q0C$T-D4Y-#E%-3,Y,#,V,R(@<W1%=G0Z=VAE;CTB,C`Q-"TP,RTR
M-50P-3HP,CHT-"LP-3HS,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@
M4&AO=&]S:&]P($-3-B`H5VEN9&]W<RDB('-T179T.F-H86YG960](B\B+SX@
M/"]R9&8Z4V5Q/B`\+WAM<$U-.DAI<W1O<GD^(#QX;7!-33I$97)I=F5D1G)O
M;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(O/B`\+W)D9CI$97-C<FEP=&EO
M;CX@/"]R9&8Z4D1&/B`\+W@Z>&UP;65T83X@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`\/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]04D]&24Q%``$!```,
M2$QI;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S<$U31E0`````
M245#('-21T(```````````````$``/;6``$`````TRU(4"`@````````````
M```````````````````````````````````````````````````18W!R=```
M`5`````S9&5S8P```80```!L=W1P=````?`````48FMP=````@0````4<EA9
M6@```A@````49UA96@```BP````48EA96@```D`````49&UN9````E0```!P
M9&UD9````L0```"(=G5E9````TP```"&=FEE=P```]0````D;'5M:0```_@`
M```4;65A<P``!`P````D=&5C:```!#`````,<E120P``!#P```@,9U120P``
M!#P```@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@*&,I(#$Y.3@@
M2&5W;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````````$G-21T(@245#
M-C$Y-C8M,BXQ```````````````2<U)'0B!)14,V,3DV-BTR+C$`````````
M`````````````````````````````````````````````````````````%A9
M6B````````#S40`!`````1;,6%E:(`````````````````````!865H@````
M````;Z(``#CU```#D%A96B````````!BF0``MX4``!C:6%E:(````````"2@
M```/A```ML]D97-C`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````
M`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````````````````
M````````````````````````````````````````9&5S8P`````````N245#
M(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="````
M```````````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A
M8V4@+2!S4D="`````````````````````````````&1E<V,`````````+%)E
M9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````
M`````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y
M-C8M,BXQ``````````````````````````````````!V:65W```````3I/X`
M%%\N`!#/%``#[<P`!!,+``-<G@````%865H@``````!,"58`4````%<?YVUE
M87,``````````0````````````````````````*/`````G-I9R``````0U)4
M(&-U<G8````````$``````4`"@`/`!0`&0`>`",`*``M`#(`-P`[`$``10!*
M`$\`5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D`K@"R`+<`
MO`#!`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!'P$E`2L!,@$X
M`3X!10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y`<$!R0'1`=D!
MX0'I`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"A`*.`I@"H@*L
M`K8"P0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R`WX#B@.6`Z(#
MK@.Z`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$F@2H!+8$Q`33
M!.$$\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&
M-P9(!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'=`>&!YD'K`>_
M!]('Y0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H)3PED"7D)
MCPFD";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY"U$+:0N`
M"Y@+L`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H-=`V.#:D-
MPPW>#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1`F
M$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2
MXQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]
M%>`6`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48BABO&-48
M^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'`(<*AQ2
M''L<HQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@
M%2!!(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P
M)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*`TH
M/RAQ**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB
M+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ
M@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R
M-JXVZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[
MZ#PG/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F0.=!*4%J
M0:Q![D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'
M>T?`2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV3
M3=Q.)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_94
M0E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU
M6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA3V&B8?5B
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MBS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2XY--D[:4
M()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUD
MG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG
M;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@
ML=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\
M(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#
MQT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2
M/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6
MWAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;I
MT.I;ZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>
M]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X`#D%D;V)E
M`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#_\``$0@`*0$$`P$1``(1`0,1`?_=``0`(?_$`:(````&`@,!````
M``````````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)
M``H+$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A
M)#,74G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"
MTN+R9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25
MEI>8F9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X
M^?H1``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$5
M4J%B%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)5
M9756-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'
MEZ>WQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ
M^O_:``P#`0`"$0,1`#\`WNNQ>P<3USMZISV4Q^Y,VR1SB@V]LW;F6W9NS/UL
M4+S1XO`X'#P35-97U&C2NLQ0J3=Y$6[!19VK7\PAC=%6H#,S:44$@59O("N3
MGI#N-]%MUL\\JNS`'2B+K=R`3I1/Q,:4`P*^?6KK_,Z_F8?S0,-MG.1=3?$;
MO'X;]$%9X,CWSNW:=!NGM&JQ\[2(*N:OVM4[LV7TC!4TY'[D\E;7PD:EJJ=^
M!E+[6^UWM5<3VK<P\Y6&Z[X^5M8Y/#1"<$'4%,YR`&&D4^)&X]8L^ZON?[I6
M5J_]7>4[W;=F()::1&:3R8%F(T0T`(9$8FIJDOD=4G)[@SNY,G/N+<&YMP[J
MS>1G>OJ]Q;BW%EMQYK(U-0[3O75&<RE;69&>::60N'\OU-Q[S)M+.TVL';MO
MVRUCM(D`"\,,,::"G[.L(+V]W3<IC<WMQ(]T7KXC"C*5.:#C6OQ:LU%:D]60
M?";^;!\L_A1N3$)C][[B[DZ8BJ(UW'T7V/N7(Y_&5F*>6]8=B;IS<V1S?7FX
MXH79Z5X9)<9),%6II)$]2Q1SS['\H<W6%V4M!8\R\8)H0-#,<TN<`:`>#9:G
M`CJ9?;_WPYJY0O+5)=VDO]ER)HKFH5144\$`G-!^`"A)++)\/6^]\9_DCU5\
MK^E-C=\=/9LYC8^^<:*FE2KC6FSN`S%)(U+GMI[HQJR3'$[FVWDHI*6L@U,@
MD37&\D+QR/SZYEY=W7E'>[WE[>;8Q[G"[`C\+@'$D;8U1N*,K4%0<@&H'1#E
MKF3;.:=DL]]VF96V^6,-@@Z#0:HVI6C(QTFA*G#*64AB8#V2]'W7'4NK3<:K
M$V_-@;$_[<^_=>ZY>_=>ZZN+@7Y-[#^MOK_O?OW7NN_?NO==7%[?GW[KW7?O
MW7NN#2(ILS*IM?DVX)L+_P"Q]^Z]US]^Z]U[W[KW7O?NO==!@25_(^HL>`;V
M/T^AL;'\V]^Z]UZXO;\D$@?X"P/^VO[]U[KUP"!?D_0?D^_=>Z[OS;GC_`VY
M_P`?H??NO==$@6N?J;#_`!]^Z]UW?_7_`-L??NO==%@HNQL/ZG@#_7/T'OW7
MNN_?NO=>O_O/'OW7NO>_=>Z]_OOI?_>O?NO==`@_3_C7^P/Y]^Z]UX,#]#?D
MC@&UQ<$7^@((M_K^_=>Z]<7M?GZV_-KVO;^E_?NO==:EU!+C41<#\VY_XI[]
MU[KD2!]?]]?@?[$GW[KW75Q_7G^GY^E_I];V]^Z]U__0V3/G3_.]^*?Q$JL[
ML/8]6WR+[XQ9FH*K8/7>7I1M/:66@6WVW8_8X2LP6"EI)G(GQU"N1RR.C))3
MQ?J$P\@^QW-_/30SW$3;=RZ&4^/(&#,OF$3!<GR!95(R&/#J$N?/?'D_DA9H
M(+A+_?V5E$4;`H&%<.^:"HH=*L0<-H'=T%/\E7YY]\?S`-S_`#)SOR$SNVJB
MGV[6]2T>R.J]K8*GQVR-B[5W%0;^&8HZ$5GW>=W,V9J*"-*JMRM1/),80J)#
M$!'[//>[VTV?VWM>38-EEFDNI5N!/.Q()FA,5-`&-/>2,#[//HF]C_<K=O<R
MYYPNMT$:6D?@>%``"%CE,X-1QRL:@BK=Q8US05I_SS/Y46V>BJ&J^:/QGVU2
M[;ZOK<W#!W_U7@J40;=V'E-Q9".DQO:VR\;!&L&#VMELU5QTF<QL(2EH:BHA
MJJ=$B:I$<I>P'O!N.Z75CR%S5N/B$`BUE>E:4)>-V)J2``4)J2`P)J!JBO[Q
M/LOMUI:3<\<K6'A$'_&(TX5)`1E4"@!)*\0%;0JBC436<(L2#P1]1_0_T_V'
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M9S?\X"2BW[/`M9486+MWY397!IDW19'BEWI+74.3E"3<&H&(+&VH*?I[]U[J
MIOL?YZ_\*"?Y!/R7PG3OR'[_`-[]B8R&DIMS[>VQW1N[+_(KH?NG8AK6I:BK
MV5O+=SQ[WQ6+%93/!41X^NP.:QTND3PQ"11)[KW6\)TO_/G^-G9?\H#>W\V/
M+X/)8;#]4X:OV]VGTG39>EJMP8'Y`457M_;V/Z>Q6?>E2"MIMZ[EW?AI<1E)
M*92N%S%/5U-/#)'44\7NO=:16+_F^?\`"@O^='\G9>G?A[V;O?KNKS<&4SN/
MZG^--9CNHMF]6]?TF1@HZO<^_.W*J6DW9'B,5_$Z6"IR>6S=JFLECAHJ=9JB
M"E;W7NK0)OY&'_"IJ/;L.4B_FQ5U1F6ADF?;"_/'Y9QUD9C5'BIDR<NQEQ$U
M3+<K_GA"&',FDZO?NO=5I?&[^?I_-T_E9_-RL^/?SR[9WKWULCJ_M.DZY^2'
M4G;5?A.S]T8K"4V0IJ//[AZU[3AJ)-Q3;CH<'5?Q#$ELM48?)7B$\3+)K3W7
MNKF.U/Y'?_"C_>O:79F\NLOYP51ANMMW]A[WW3U[B7^8/R]PSXW8^X-S93+[
M3H7PV)V+4XG#-2X&LIT-)2RR4U,1XXF9%4GW7NM:?^8YW+_.@_ED_*#.?%/N
MW^9_\F]X[[V_M/9V[ZS-]8_*WY!Y+:LE!O3%?Q;'4U/4[FR&V,J:RFA.B8/1
MHH;E2RD'W[KW5UGQG_E(_P#"D?Y4?'?I#Y*[`_G";EP^R>^>KME=L[5Q&Z_F
M9\NZ;<V+P&^L%1[AQ-!N"##[1S.+AS%-0UR+4)3U51&DNI0[6]^Z]U-_FL[=
M_FS_`,IG^4#T]M7OW^8)VYO/Y,[]_F1;DW!0]T=1?(GO'(9J/HVO^-24.+ZO
MRF^]SIL_>4^+I-^;5R&7&+T28Z*6L65"92VGW7NK<?\`A(/\C_D'\F/A1\F=
MW_(KO#MGO;=.#^5$VWL+N+M[L'=/8F;Q&!3J/KK)##8S*;LRF5KJ'%_Q"NFG
M^WC=8A+*[A=3,3[KW5['\U?>&[>O/Y:7SUW]L#<^?V1OK9GQ([[W+M#>6U,M
M6X'<VU]Q8;K?<&0Q&=P&:QTU/7XG+XRNIXYJ>HA=)8I$#*P(!]^Z]UHC_P#"
M6;Y]?,OO?^:&=H?(_P"8OR*[:ZSQ?QF[IW16;:[A[QW_`+TV515>$J-FO%GZ
MS&;OW%D<-33XBEDE=:MT5X$+G6%+7]U[I(?S0/\`A4A\X_ECW_FNA?Y:NYMQ
M=(=&-O>+KSK/-=;[<&2^0_R!RM7EVV_A\S2Y>KH,CF]ITV\\K/`<'A,%3T>6
M6.:-:JHFFD^WA]U[HV/3W_";C^?)WQM+'=G?(W^9]O#I;?6Z:-,M4[#W/\@?
MD#VOOK`O6QI4#&[PRFW=R0;4H,K&TA$L..R64@B(L)";J/=>Z(S\VNB/^%#G
M\A`[<[C;YS=M]A=$9C<E!@*+L_8_;V^NVNK<9N>>-ZO%[<[.ZG[HH<A0[=KL
MPE+,M--/C*O&5)7PI6&=Q"?=>ZVI?^$\_P#/LK/YKNT-_P#3'?\`AMK;#^7'
M2&VL?N_-UFU@<=L[N+K%JNEP=?V-@\)65-5/M;.[8SM724VX*`2/0*V2HZFC
M=(YY:2A]U[K6E_F,?\*7_P"8I\T/ES7?&'^5UN7/]5]55W9<?4G32=6[>PF9
M[N^0N<DS4FV\7NJ?=>9QN1J]L8W>&1=:G%X_$C&FDH9(S75$KARGNO='2V+_
M`"0_^%2W9.,BW1V-_-FSW4N<R5/%45&T\Q\UODOFLOBI70,<?D5ZSVWFMF4]
M3`[%6%!755/Q=9&'OW7NEP_\@/\`X4J%2O\`P]M5M?\`LM\N?FL`>?ZC9+$<
M?X>_=>ZIR_X4*_S"OGQT;_-W^6?4G4'S5^4_6'7VS*/X^X;%[(Z\[X[/V9L[
M&5S_`!@Z9J]T56&V]@-S4&-H%S^ZJJNR,SI$DD]15R327D=C[]U[K:`_F+_!
M7^8-\I?Y<GQ/^7_P!^8WRUV)\L-H_#SH7,=D=2[&^0G9VU\!\GL.>K,'N+.9
M6FPV'W)0XU?D`M=D9YX:XHK;C1C1U!:<4DB>Z]U3=_PGF_X48]K]9]RK\'/Y
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M+^"_W_[(^^_O?_Q^_P!COC_9>/[]_9^;[#^(_P`)_P!FI_V67^"<_P`1_A/F
M_P!)'^1_;?PO_*_?NO=?_]&HG>=!68C?/8.'R,;P9'$]B;]H,I3R7UQ9>CWA
MFJ;+"4D*7G.1BD+L1=FN3R??7':Y+6ZV7:FM:OMI6-X0#08`)?'Q"OEP/7'G
M>!<VN][FMW'3<!5)6;)';I"`'@:4`/E2@ZN@_P"$_P!\E,5T;\Z5ZZW/7)CM
ML_)S9<O6=)4U$IBI(^R\#7G<_7B3$W02YN)<GB:<6O)65T"7N1>$?O(<KW6_
M<AC=K*,O/M5Q)<.!Q,,M!(?*GAG02<U4$GAU//W9N:K?9.=7V>Z8)!N$"PJ?
M^&KI\,D_TBN@#^*3'GUO&=D[`VOW!U_O;J_>N.BRFS^P=I[AV3NG%5,$<J5N
M#W-BJO$Y"'3.CHDHIZDLC6)1U!'(]X!;9N-WMN[;;N5F2D]N\<Z'-30UTGA3
M(!/V4]>L^-TL;?>MKW+:KM*VUQ')`PH"!44UBO&G%?G0@U'7RYNSNNLST]V=
MV5U#N)Y)<]U5V!O+KG*S2J5DJ*K9NXLC@%K&!Y_R^GH4G!_(D]]:]BW=>8-C
MV;?54+]9:Q3:0:A=:@Z:^=/4@$^8ZY(<R;5^X]_WG:!D6]U)'6FG45<@G3G2
M-50!4@`#)Z.=_*BJLA2?S)_AA+BVD6ID[A-)+XKZCC*S8^\:;,(^D@F$XR24
MM?BPO;CW'WO;%%_K7<ZF;)I"17UU*5_G2GSZD/V',I]T^4_"6A!?]E:,?]Y+
M?E7J[C_A9BFZF_E2=?M@S/\`P-/F+U2=Y+`+@XH]=]Q+BONB!<4@W(:/_#SF
M+\V]\S^NH/50W_"'X;%_TV?/\Y#^'GLS_19T>-L^<0_Q0;%.[-^'??V#-_E'
M\/.?&W?O`HT>04VKG3[]U[KZ)WOW7NM%[_A<`VQAT/\``E*UJ#_24.W.Y7VR
MC&/^)C8S;-V@-\-"O^=%`<^-O"0_I\GC_/OW7NM9KX_UV[*3_A.I_,.@::NB
MV?E/Y@?Q"H:1#Y!CZC,1[.W;D]RPQ`VC-4L>/P4DX%R!'#<6T^_=>Z=?Y&':
MW\Y#J$?)3.?RD.B,3VU79J/JS%]YYZKZ^V/O3);9IJ27?E5L'$T5=N_.X6HQ
M-'G9)LK-/!2^1*MJ.-Y1>GB*^Z]U9C\Q?YYO_"GCX0X[:$?ROV/MCXZ1=G#-
M0;$W)F_CUUE5P96JP'V@S-/C,C#5[KVX,KC$R,$KTM4AE\4J2>,QG4?=>Z+W
M_)Q_DK=R_P`[?NS(?/#Y/?(S8VY>F_\`336;A^2$*;L_O+\C.Q=Y4F6@SN0V
M9F-H8RAHZ#KC%;[H@%BR=341)38J56Q]',(]$/NO=?4_@CCB@ABBB2"**)(X
MH8U")#$BA8XD10H1(T``````]^Z]U\G;_A7%_P!OG>T/_$)]!_\`O$I[]U[K
MZ+W\F3_MTO\`RX?_`!3'X]_^^UV_[]U[K7I_X6U?]D(_$G_Q;9__`'SG8GOW
M7NM;S^21UU_PH+WG\=>U*S^43V-3;1Z.I>Z)Z;LG&3[C^/&'DG[8&Q]J2U-?
M'!W%B,AG"C[/EQ4;/2.E(YC4:3(CD>Z]U8A\O>FO^%>V'^*?R2ROR@[CI<A\
M;L?T=V?5=]8Y-Z_#RHDR/3\&T,K)V+0)!M/`0;FG^\VFM5&T>/D2LE1BD1UL
M`?=>ZI>_D$C+-W/_`#`EVX*C^];_`,G[^8:NTC1Z_O1N4]98W^%&C\9$GW7F
M_P`WIYU6M[]U[I'?\)TO[C_\/3_`?_2`,><)_I1W'_#!E?!]G_?G_1=OW_1N
M5^X]'\1&_P#^&_8V_<^^\.CU6]^Z]U]DH$&]K'D@V_J.#>WY!]^Z]U2Y_P`*
M()-EK_)<^?W]^&H/X0>I,0E`*TP>/^^;]C[)7KX1B8Z?O?[]_P`.\%O7Y@NG
MU6]^Z]U\XG_A/1F]U[:^9O>NY-J3UU-)MW^7=\\<YEYZ)WC6&@Q70V>KL7+6
MR(#XZ:+=T.,9#^*D1'ZV]^Z]T37^5'#\VI/GIT<_\NK%8/,?,6E._P"KZ@IM
MPTO757C(98NL=XG>=?)'VNZ;$CFH-@-E98Y:T@Q.H>$B=8C[]U[K<G_O#_PM
M]_YY[8'_`)P_R\/^)KK^_=>ZN!_DS97_`(4*5W?7:4/\WW&;9H>CX^H3+UG)
MA:3XQ0U+]K'>6WDB0S=%5$V<,(V@,F9%KA]GJ,96TEK^Z]UH4_\`"F[_`+?A
M_.C_`+771_\`\#3TY[]U[KZL'P)_[(6^%U_^\3?CG_[Y_9UO]Y]^Z]U\WG_A
M6Q)_+LE^?$2_%$2GY6+#E4^;LFQ3B3TV^^`U(NWXJE:7]U^_XXA.-X&D/V5_
MM157S0R8'NO=%5_X3=;U^`/4G\R[8]=_,'PM3B\[05M/BOC=N?>\M!1]1=7?
M(>EROBQ.9[CP^4AAJL?74]0B4^`RE4_\.V_G=%360HRPY#'>Z]U]=V/2RBZJ
M''ZUXU*_!:_^))O?\WO[]U[K+[]U[K__TDO_`#M_BWE/C5\\.PMQT^,EI^M_
MDO+6=W;`R*4WCH#GLK+3P]J[822)13+DL)O*8U[1"S+1Y>G8BQ)]]%/N]\Y0
M<S<@;582O_NSVJ-H'CX,JO\``S>HTBE?XE;TZYM_>(Y/O.7.>MQW&.)1L^Y.
MLJ.`*$_$P!J<B1G!%!1?"_B%:DZ6JK*&KH\ACJZMQ>3QM;1Y3%97&5,U%D\3
MEL950U^+RV,K:=DGH\EC*^GCG@E0AHY8U8<CW-DZ031/;W<0DM904=#E65A0
MA@<%?4''4%VUS/9S)>6LQCN8NY6!(((]"""*BHJ"#Z$&AZWM?Y3O\X#87S$V
MCM_IGOC<6!V'\ML!1TN(GH<A44N%P/?$%'&L$&].MWG>*D.Z*Y`K9;;R,*FF
MJ2\U+')2']GG7[N^S>[\BW]QNNV0M-RC/(Q1EJQAQ7PW/$#@58XH#JHV6Z0^
MSOO)L_/NV6=AN%V(N:(D575Z#Q34C4O`%Z`Z@`-1.I!0,L>I+_,U;'O_`#%/
MFL^,T_:GY!;P5])4C^(10XV',<J`NK^+QSZA]0U[\W]YK>TJ,GMGR5K_`!6"
M'\C6G\NL)O>4H?<OFWPS4"\E'Y^*]?YUZLB_X3P?%G,]J_+/+?)O(T#_`.CG
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M?@#_`,*"/Y^GR8PO='R*Z$WEUKBZO'TFV]O[K[JVGE?CQT3TUU\N0DJVHMD[
M-W5'+OK*XL5E7)/,V/H<[F<A,0U1-*$#1^Z]U?S_`#4OY/&=^&/_``GIV9\$
M/B%UKVC\F^TYOD[U?V3VKE^L.O,WNG>?8_8.4QV?_OOV34[+VM!G,GB-IXZ#
M%XW#4$2_<&@QM-0QU$\TOFJ)/=>ZP_\`"./XI_)_XOX_^8#2_)+X[=V=!2;Q
MK_C7)M$=Q=9[NZX.ZA@J7N[^.C;T>[<5BI<O_!!F*,U30JZP_=Q!C=[>_=>Z
MVD/YAOP*Z._F2_%CL'XL]]8UCMW==/'EMI[QQ]-3S;HZM[%P\-2=I=D;/FGT
M>#-[?J*F1)8M:19''5%505&JFJID;W7NOG-_`WH?^=3_`"'_`.8QNK)["^%/
MR>[]ZLP6X_\`1SWGBNG>HNS=\]-_)+I]*XUF,W5L7=.#VY7X7^\='CJH9?;=
M<Y6OPU?++05T21S9.AE]U[KZ@O6'8>([7Z[V5V5@\5NS`8K?&V,/NBCP._=J
MYG8^]\##F***L.%WAL[<5+19S:^YL2\AIZZAJHDFIJF-T8&US[KW7S8/^%0'
MP)^</R%_FT]E=C]$?#WY-=Q]>U74'26-H]]=8](=C;YVC6U^+V>M-DZ.CW#M
MG;V3Q4]7CJI6BGB$ODBD4AE'%_=>ZWT/Y2VS-W]=?RP_@)L+L#:VX=D;XV=\
M2^C-M[MV?NS#U^W]S;9W!A^O\)0Y7"9[!Y2"ER6)RV.K(7BGIYXXYHI%*NH(
M(]^Z]U1;_P`*^_C?\A/DQ\,OB]M+XZ=&]M=[;GP?R?DS^;V_U#U]NGL3,X?!
M_P"BG?6-&7RF,VGC,K6T.-:OK8H1/)&L7ED5-6IE!]U[K/\`\)!_CC\@OC/\
M*?DUM#Y%=']L]$[JS7RHFW#AMN]N]?[IZ[S>7P3=2==8T9G&8O=F+Q5=78O^
M(4,T'W$:-"98G0-J5@/=>ZO9_FK[/W;V'_+1^>VPM@[7S^]M\;R^)'?>VMH[
M.VIB:W.[FW/N+-=;[@Q^(P6`PN.AGK\KE\I7U"0T]/"CRS2N%522![]U[K1&
M_P"$LWP'^9G0_P#-$?=WR-^'?R*ZFZUR?QE[HVQ6[C[@Z.W]LO9=95YRHV:L
M&`K<IN_;F/P\U1F*:&5%I7=GG0.-!4-;W7NDK_-!_P"$N/SB^)GR"RW?W\M#
M;.XN[.CX]\0=C=983KK<:4'R%^/F8HLH=Q8G#4V(K*[&Y?=]%L[+P0C`YC!U
M%;ERD4?W=/'-']Q/[KW1MNIO^%)O\]GH;:F/ZT^27\K?=_;V_=M4J8RKWUN#
MH/O_`*@WGN"6C5(7RF[L+@]KUNU*S+SLMY9L9C\732$@B%;DGW7NB(?-GO'_
M`(4._P`_([:ZE'P9[9Z]Z$P^YZ#/8WK+9G46]NI^JLCN>*GEH\9N7LOMCNBN
MQM#N7(8B*KF:FCFR5)C*4/Y4HQ.HF]^Z]UL)_P`KW_A/SN7^6)\"?GKV)VG+
MC.VOG#\C/A_W7UQ1[<ZTI:W<..ZWVED>M]P5U%T_L:L:DI\GO?>.^MWQ4$F7
MJHH(Z:>JQ]#24*,D,E77>Z]UKI?\)QOY?7SPZ-_G#_$GM+N;X8_*/JCK/`TW
M=IS_`&!V-T5V3LK9N!3+?'WL_#8M\QN/<FW<;BJ#^)9G(TU'`LDH>6IJ(T4$
MGCW7NOJ9CGD?0^_=>Z][]U[KY6'_``H<_EY_/7O#^</\SNTNF_A9\J.U.M-R
M9?J&7;F_^O>ANS=X[/S\6'^/W56#RDN%W%M_;60Q63CH,SBZFEE,,K^.H@=&
MLRD>_=>ZV5/YD?SN_F-?'3^7O\6?A-_+T^&OS"W/\FLS\0OC[@NYN]]C_'GM
M'.X?XXXZ;J3;N*S.R]GY[$[;K*"7Y`224LD53)&[_P!TH&$JD9.2!J'W7NJV
M_P#A.1_PG7WYE^QJ/Y\_S)^J=T;7.Q]TR9?H3XX]O83(XG>&[-^X[(?<S=U]
MS;7W+!'F:/`8',HTF"Q60B2IS&3C-?4HM!#3#)^Z]T8?_A3Q_P`)^=P=YY++
M?S$?@EUGD-R]QSFF7Y.]#;"P=1DLYVI&YAH:+NGKW;6'@DJ\EV%CUT0[EQ])
M"\F9I0F2C05T%<^1]U[HR/\`PG*^=_\`,@VU@-I_`O\`F1?$'YC[;QF$Q?\`
M!_CA\J.R/C_VYCL%387#XVHJJ?J+NC>>;VW#1X_^'8^B\6V<W63*DL2+CJEQ
M(M(\ONO=;@WX^OX^O_$^_=>Z_]/<(^?_`,%NM?GST%E.H-ZS_P!W-RXRM.Z.
MJ>R*''QUN8ZXWY34DM-296"G<PG)[?RE-.]'E\:9$2NH9&`:.>.":(9^WW/^
M[^W7,EOOMA"6AD2ES%JHLD?G7CW?PFA((X$%@0!S_P`@[3[@<N3;!?N(W+:K
M:2E3&<=OD0AI0@%3P8$.B,NGAL7^0Y_,0W1W5F>H<_L7:&P]N;:J8OXOWWG-
MQ19'J7+8>I,S4>6V!38QFWCNVOK((=?\+EHZ"6BD98ZR6#AFS5O?O'^W=ER_
M;[K9R37=]*O=9E"KI)0]QD/;X:4RH)#5&G53K"NS^[/SY=[_`#[3=I'!M:$E
M;K4""@IVD"M6;5VL$)[6U+'7&P%U[_+I^#/\HOIW(_)O>N"ROR-[TV1!!4[.
MW=O+`KN'>>Y>TZOST>R-D?'WJG"TV0HMO;OW1GJF"EHWHX*_,0(9)Y*T0QRN
MF,^[^Y_/WN_N]ARRNZ16'+4\]943LC2W%3(\C=NHH@_$0&!90I8@')?:/;+D
M?V?V*[WZ/;C>\QQ1`1%^XO<$TC2-372"[#N8LT8`?4JJ:5:?%'^0[\E?E1O/
M,?(#YY;DR71&'[+W=GNQ=Q[`PKT.3[RW7D]W9VJW+E8\G62#([<ZKHJB;)RH
M%G7*99%4(\%,XU"8^;/O!;#RGM5KRG[86PN/HX5MQ=2BL7A1K1-"&E7XAF6@
M;X@QZB;E;[N^[\V;Q>\U^XMPT"W4[3&"($2.[N2_BAJ^&K4UKJ)(U%6C!%>M
MMKX^_'WJ7XO]3[6Z8Z0V;C]C]>[2II(\9AZ-ZBIJJJMK)C4Y3.9[+5LDV2SV
MX<Q6,TU76U4DD\\AY-@H&'W,',&Y<T;E<[YOU])/?2-EV)-0,*JCR04`51@#
MK+S8]AV[EK:;?9]FLHX;2.E%7UI0LS'+L?-CDX&``.AN]EO1SUT%4$L``3]3
M;D_ZY]^Z]UW[]U[KHJK?J4-;^H!_WOW[KW7K"X-N0"`?Z`VN/]8V'^V]^Z]U
MZP_WW/\`O?OW7NN_?NO==6`X'`M:P^@'^`_'OW7NO!0"2`+FUS;DVX%S]3Q[
M]U[KNW^^_'^V^GOW7NO>_=>Z]_OO]]_M_?NO==6%[_D<`_6U[7_V]O?NO=>L
M"02.1]#_`$N+&W^P]^Z]UW_OOK?_`'OW[KW71`-B0#;Z?X>_=>Z[]^Z]UX@'
M@BX_H>??NO=>]^Z]UU8&]^;_`%!^G]/I]/?NO==^_=>Z][]U[KUO?NO==6'T
M^G^MQ]3<G_7)]^Z]UT$0,7"J':P9K#4P`L`6^IL/?NO==V%P;"X^AMR/?NO=
M>(!O?F_!'X_VWT]^Z]UW[]U[K__4W^/?NO=>]^Z]T7KM/_F<WQD_\.[L?_WU
M.Z/:Z'_DF[E]L/\`U<Z++C_DK;5_I)_^.KT80?G_`%S[1'HQ7S^WKOWKJW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
>NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
